Jasper Bos, PhD, General Partner, will represent Forbion at the Future Healthcare Investment Market (FHIM) 2026 in Shanghai, China, on 4 November. He will participate as a speaker in several roundtable discussions exploring the next chapter of China–Europe biopharma collaboration.
Jointly developed with IPEM and Healthcare Business International, FHIM connects senior healthcare decision-makers, investors, operators, innovators and policymakers from China, wider Asia and Europe. The event focuses on accelerating cross-border cooperation across biotechnology, medical technology, healthcare services and private capital.
FHIM provides a platform to build trusted partnerships, exchange perspectives and explore investment, licensing, clinical collaboration and market-entry opportunities shaping the future of healthcare innovation between China and Europe.